secwatch.observer — SEC 8-K summary
======================================

Issuer:     Connect Biopharma Holdings Ltd (CNTB)
CIK:        0001835268
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001835268-25-000061
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Connect Biopharma board member Kan Chen resigns amid U.S.-centric shift
-----------------------------------------------------------------------

- Kan Chen, Ph.D., partner at Qiming Venture Partners, resigned from Board and Nominating Committee effective Dec 17, 2025.
- Resignation not due to any disagreement with company on operations, policies or practices.
- Chen cited company's successful strategic shift to become more U.S.-centric as appropriate time to step down.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835268/000183526825000061/0001835268-25-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835268/000183526825000061/cntb-20251217.htm
  HTML page:      https://secwatch.observer/filing/0001835268-25-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer